This grant is requested to support a basic research program aimed at elucidating at the molecular level the nature, mode of functioning and regulation of the specific receptors for dopamine. Physiologically, dopamine exerts effects such as regulation of hormone synthesis and secretion in the periphery and control of cognitive, affective and neuroendocrine functions in the central nervous system (CNS). For a long time, these effects of dopamine were thought to be mediated by only two distinct G protein-coupled receptor subtypes Dl and D2, coupled respectively to stimulation and inhibition of adenylyl cyclase. Recent developments from several experimental approaches but in particular molecular biology now suggest that the family of dopamine receptors will be much larger than previously anticipated. The cDNAs and genes of three distinct dopamine receptor subtypes have already been isolated. In order to characterized these systems, the work proposed in this application (six specific aims) can be divided into two main lines of investigations. First, we want to determine using the molecular biology approach the extent of this receptor family and determine the physiological significance of the apparent heterogeneity of receptors for dopamine. Second, we want to examine the biochemical mechanisms of action, regulation and interaction of the various dopaminergic receptor systems as they may underlie pathophysiological situations. In order to characterize these mechanisms at the molecular level we propose to develop procedures for the over-expression and purification of every member of this receptor. family using the baculovirus-infected insect cell system. Elucidation of the basic molecular mechanism of signal transduction and regulation of the different subtypes of dopamine receptors may help in understanding the etiology of certain CNS disorders such as schizophrenia, Parkinson's disease or peripheral disturbances such as hyperprolactinemia. This project constitutes an integral part of the overall long term objective of this laboratory to characterized at the molecular level the Various receptors for catecholamines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS019576-09
Application #
3399672
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1983-12-01
Project End
1998-11-30
Budget Start
1991-12-15
Budget End
1992-11-30
Support Year
9
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Marion, Sébastien; Urs, Nikhil M; Peterson, Sean M et al. (2014) Dopamine D2 receptor relies upon PPM/PP2C protein phosphatases to dephosphorylate huntingtin protein. J Biol Chem 289:11715-24
Philipp, Melanie; Berger, Ina M; Just, Steffen et al. (2014) Overlapping and opposing functions of G protein-coupled receptor kinase 2 (GRK2) and GRK5 during heart development. J Biol Chem 289:26119-30
Burkhalter, Martin D; Fralish, Gregory B; Premont, Richard T et al. (2013) Grk5l controls heart development by limiting mTOR signaling during symmetry breaking. Cell Rep 4:625-32
Philipp, Melanie; Evron, Tama; Caron, Marc G (2013) The role of arrestins in development. Prog Mol Biol Transl Sci 118:225-42
Evron, Tama; Daigle, Tanya L; Caron, Marc G (2012) GRK2: multiple roles beyond G protein-coupled receptor desensitization. Trends Pharmacol Sci 33:154-64
Evron, Tama; Philipp, Melanie; Lu, Jiuyi et al. (2011) Growth Arrest Specific 8 (Gas8) and G protein-coupled receptor kinase 2 (GRK2) cooperate in the control of Smoothened signaling. J Biol Chem 286:27676-86
Berlanga, M L; Price, D L; Phung, B S et al. (2011) Multiscale imaging characterization of dopamine transporter knockout mice reveals regional alterations in spine density of medium spiny neurons. Brain Res 1390:41-9
Ramsey, Amy J; Milenkovic, Marija; Oliveira, Ana F et al. (2011) Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner. Proc Natl Acad Sci U S A 108:5795-800
Sotnikova, Tatyana D; Beaulieu, Jean-Martin; Espinoza, Stefano et al. (2010) The dopamine metabolite 3-methoxytyramine is a neuromodulator. PLoS One 5:e13452
Abbas, Atheir I; Yadav, Prem N; Yao, Wei-Dong et al. (2009) PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors. J Neurosci 29:7124-36

Showing the most recent 10 out of 132 publications